Broad agency announcement: FDA-BAA pmwp#85- extending the value of common data model harmonization in the generation of clinical evidence from real world data sufficient to support regulatory use
Ended Definitive Contract Awarded Last action
- Contract number
- 75F40119C10056
- Awardee
-
Elligo Health Research, Inc. UEI YHXZE6Q2CEG7
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $350,000
Award facts
- Opportunity
-
- 1216000 Solicitation number
- Contract value 100% obligated
- $350,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 11 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
- National interest action
- Coronavirus COVID-19
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $350,000 |
About this award
The Department of Health and Human Services Food and Drug Administration awarded a $350,000 definitive cost-no-fee contract to Elligo Health Research, Inc. to support the agency's Broad Agency Announcement seeking proposals to extend the value of common data model harmonization in generating clinical evidence from real world data sufficient to support regulatory use. The small disadvantaged business will perform work at locations in Silver Spring, Maryland under the contract addressing the FDA's goal of leveraging real world data on the Coronavirus COVID-19 pandemic. No set aside designation was applied to this award made on August 27, 2019 with work to be completed by March 15, 2022.
Quick answers
Who was awarded contract 75F40119C10056?
75F40119C10056 was awarded to Elligo Health Research, Inc. by Food and Drug Administration (Department of Health and Human Services) on August 27, 2019.
How much is contract 75F40119C10056 worth?
The government has obligated $350,000 on 75F40119C10056.
Was contract 75F40119C10056 competed?
The extent of competition for 75F40119C10056 was full and open competition. The government received 11 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award